Statera Biopharma, Inc. — Form D

Statera Biopharma, Inc. of Fort Collins, CO, a company, filed a Form D exempt-offering notice with the SEC on 2010-03-05. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (56)

Showing 25 of 56 people.

NameRoleLocation
James AntalDirectorBuffalo, NY
Paul DiCorletoDirectorBuffalo, NY
Michael FonsteinDirectorWestport, CT
Andrei GudkovDirectorBuffalo, NY
Bernard l KastenDirectorBoulder, CO
Yakov KoganDirectorSalt Lake City, UT
Daniel PerezDirectorSan Francisco, CA
Michael FonsteinExecutive OfficerWestport, CT
Andrei GudkovExecutive OfficerBuffalo, NY
Yakov KoganExecutive OfficerSalt Lake City, UT
Jack MarhoferExecutive OfficerBuffalo, NY
Richard S McGowanDirectorWESTMINSTER, MA
Robert Kevin BuckheitExecutive OfficerFort Collins, CO
Blake Kevin HawleyDirectorFort Collins, CO
Satish Kevin ChandrenDirectorFort Collins, CO
Uday Kevin SaxenaDirectorFort Collins, CO
John Kevin KallassyDirectorFort Collins, CO
Michael Kevin HandleyDirectorFort Collins, CO
Michael Kevin HandleyExecutive OfficerFort Collins, CO
Michael Kevin HandleyPromoterFort Collins, CO
Christopher Kevin ZoshExecutive OfficerFort Collins, CO
Alexander S AndryushechkinDirectorBuffalo, NY
Andrei S Gudkov, Ph.D., D., Sci.Executive OfficerBuffalo, NY
Langdon S Miller, MDExecutive OfficerBuffalo, NY
Lea S VernyDirectorBuffalo, NY

Other filings by this issuer (6)

FiledFormOfferingSold
2022-11-07D$765K$577K
2020-06-04D$1.6M$1.6M
2015-12-23D$1.1M$1.1M
2015-07-16D$25.0M$25.0M
2014-07-03D$3.5M$3.5M
2009-04-03D$3.7M$3.7M

More